University of Münster
CRIS@UM
DE | EN

Anja Koschmieder

No current affiliations available for this person. The person is no longer active at the university.

Publications

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.
Krug U, Röllig C, Koschmieder A, Heinecke A, Sauerland MC, Schaich M, Thiede C, Kramer M, Braess J, Spiekermann K, Haferlach T, Haferlach C, Koschmieder S, Rohde C, Serve H, Wörmann B, Hiddemann W, Ehninger G, Berdel WE, Büchner T, Müller-Tidow C, German Acute Myeloid Leukaemia Cooperative Group, Study Alliance Leukemia Investigators (2010)
In: Lancet, 376(9757), 2000-2008.
Research article (journal) | Published
Estimating the Chances of Older AML Patients to Achieve a Complete Remission Upon Intensive Induction Chemotherapy - An AMLCG and SAL Study
Krug UO, Rohde C, Heinecke A, Sauerland MC, Koschmieder A, Rollig C, Schaich M, Thiede C, Kramer M, Braess J, Spiekermann K, Haferlach T, Haferlach C, Ehninger G, Woermann BJ, Berdel W, Hiddemann W, Buchner T, Muller-Tidow C (2010)
In: Blood, 116(21).
Research article (journal) | Published
Addition of 5-Azacitidine to Standard Induction Therapy Is Feasible In Older Patients with Acute Myeloid Leukemia: The AML-AZA Trial of the SAL Study Group.
Krug UO, Koschmieder A, Gerss J, Serve H, Steffen B, Bug G, Schaich M, Brandts C, Rollig C, Ehninger G, Duehrsen U, Noppeney R, Berdel WE, Koschmieder S, Muller-Tidow C (2010)
In: Blood, 116(21).
Research article (journal) | Published
A Novel Risk Score Predicts the Likelihood of a Complete Remission After Intensive Induction Therapy in Older AML Patients
Krug UO, Heinecke A, Koschmieder A, Stelljes M, Sauerland MC, Berdel WE, Woermann BJ, Hiddemann W, Buchner T, Muller-Tidow C (2009)
In: Blood, 114(22), 138-139.
Research article (journal) | Published